A detailed history of Baird Financial Group, Inc. transactions in Sanofi stock. As of the latest transaction made, Baird Financial Group, Inc. holds 144,101 shares of SNY stock, worth $6.96 Million. This represents 0.02% of its overall portfolio holdings.

Number of Shares
144,101
Previous 133,746 7.74%
Holding current value
$6.96 Million
Previous $6.49 Million 28.03%
% of portfolio
0.02%
Previous 0.01%

Shares

30 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

BUY
$48.54 - $58.53 $502,631 - $606,078
10,355 Added 7.74%
144,101 $8.31 Million
Q2 2024

Aug 13, 2024

BUY
$45.39 - $50.36 $438,149 - $486,125
9,653 Added 7.78%
133,746 $6.49 Million
Q1 2024

May 14, 2024

BUY
$45.75 - $52.48 $633,729 - $726,952
13,852 Added 12.57%
124,093 $6.03 Million
Q4 2023

Feb 14, 2024

SELL
$43.13 - $54.79 $481,977 - $612,278
-11,175 Reduced 9.2%
110,241 $5.48 Million
Q3 2023

Nov 13, 2023

BUY
$50.95 - $55.2 $1.47 Million - $1.59 Million
28,877 Added 31.21%
121,416 $6.51 Million
Q2 2023

Aug 11, 2023

BUY
$50.45 - $57.18 $95,350 - $108,070
1,890 Added 2.08%
92,539 $4.99 Million
Q1 2023

May 15, 2023

BUY
$45.86 - $54.45 $345,692 - $410,444
7,538 Added 9.07%
90,649 $4.93 Million
Q3 2022

Nov 14, 2022

SELL
$37.22 - $100.5 $2.52 Million - $6.81 Million
-67,781 Reduced 44.72%
83,778 $3.19 Million
Q2 2022

Aug 08, 2022

BUY
$48.99 - $57.46 $4.03 Million - $4.72 Million
82,194 Added 118.49%
151,559 $7.58 Million
Q1 2022

May 13, 2022

SELL
$48.48 - $53.65 $44,213 - $48,928
-912 Reduced 1.3%
69,365 $3.56 Million
Q4 2021

Feb 09, 2022

BUY
$47.07 - $52.35 $268,957 - $299,127
5,714 Added 8.85%
70,277 $3.52 Million
Q3 2021

Nov 12, 2021

BUY
$47.89 - $53.12 $182,556 - $202,493
3,812 Added 6.27%
64,563 $3.11 Million
Q2 2021

Aug 11, 2021

BUY
$49.36 - $54.25 $80,061 - $87,993
1,622 Added 2.74%
60,751 $3.2 Million
Q1 2021

May 13, 2021

SELL
$45.46 - $50.51 $270,032 - $300,029
-5,940 Reduced 9.13%
59,129 $2.93 Million
Q4 2020

Feb 11, 2021

SELL
$45.3 - $51.62 $40,135 - $45,735
-886 Reduced 1.34%
65,069 $3.16 Million
Q3 2020

Nov 12, 2020

SELL
$49.47 - $53.77 $506,820 - $550,873
-10,245 Reduced 13.44%
65,955 $3.31 Million
Q2 2020

Oct 22, 2020

SELL
$42.91 - $52.5 $786,969 - $962,850
-18,340 Reduced 19.4%
76,200 $3.89 Million
Q2 2020

Aug 14, 2020

SELL
$42.91 - $52.5 $227,079 - $277,830
-5,292 Reduced 5.3%
94,540 $4.75 Million
Q1 2020

May 14, 2020

BUY
$38.02 - $51.66 $367,919 - $499,913
9,677 Added 10.73%
99,832 $4.37 Million
Q4 2019

Feb 14, 2020

SELL
$44.25 - $50.86 $6.34 Million - $7.28 Million
-143,219 Reduced 61.37%
90,155 $4.53 Million
Q3 2019

Nov 14, 2019

SELL
$40.34 - $46.64 $489,324 - $565,743
-12,130 Reduced 4.94%
233,374 $10.8 Million
Q2 2019

Aug 14, 2019

SELL
$40.43 - $44.3 $59,553 - $65,253
-1,473 Reduced 0.6%
245,504 $10.6 Million
Q1 2019

May 14, 2019

SELL
$40.83 - $45.43 $290,668 - $323,416
-7,119 Reduced 2.8%
246,977 $10.9 Million
Q4 2018

Feb 14, 2019

BUY
$41.48 - $45.59 $581,881 - $639,536
14,028 Added 5.84%
254,096 $11 Million
Q3 2018

Nov 13, 2018

SELL
$40.0 - $44.84 $181,440 - $203,394
-4,536 Reduced 1.85%
240,068 $10.8 Million
Q2 2018

Aug 13, 2018

SELL
$37.63 - $41.22 $43,425 - $47,567
-1,154 Reduced 0.47%
244,604 $9.79 Million
Q1 2018

May 14, 2018

SELL
$38.98 - $45.76 $1.43 Million - $1.68 Million
-36,777 Reduced 13.02%
245,758 $9.85 Million
Q4 2017

Feb 09, 2018

SELL
$42.86 - $50.61 $252,702 - $298,396
-5,896 Reduced 2.04%
282,535 $12.1 Million
Q3 2017

Nov 14, 2017

SELL
$47.04 - $50.34 $2.73 Million - $2.92 Million
-58,023 Reduced 16.75%
288,431 $14.4 Million
Q2 2017

Aug 14, 2017

BUY
N/A
346,454
346,454 $16.6 Million

Others Institutions Holding SNY

About Sanofi


  • Ticker SNY
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,508,100,096
  • Market Cap $121B
  • Description
  • Sanofi, together with its subsidiaries, engages in the research, development, manufacture, and marketing of therapeutic solutions in the United States, Europe, and internationally. It operates through three segments: Pharmaceuticals, Vaccines, and Consumer Healthcare. The company provides specialty care products, including human monoclonal antib...
More about SNY
Track This Portfolio

Track Baird Financial Group, Inc. Portfolio

Follow Baird Financial Group, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Baird Financial Group, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Baird Financial Group, Inc. with notifications on news.